Answer
Veletri (epoprostenol sodium) is indicated for idiopathic or heritable pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue diseases in patients with WHO Functional Class III–IV symptoms, to improve exercise capacity.
Sources for this answer
- Veletri 1.5mg, Powder for Solution for InfusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.1 Therapeutic Indications · Version 14Document updated
Sources checked